On December 31, 2020, the Ministry of Health promulgates the Decision No. 5631/QD-BYT on promulgating the “Guidance on management of the antibiotic use in hospitals”.
Accordingly, the head of the hospital shall issue a decision on the establishment of the antibiotic management board in the hospital and on the missions assigned to each of its members, whose roles and coordination must be defined. Its main members include: Leader of the hospital, clinical doctors (intensive care, infection or doctors with experiences in providing treatment for infectious diseases requiring antibiotics), pharmacists, persons doing microbiological work, etc.
Besides, the formulation of general guidance on the use of antibiotics in the hospital shall be based on the following contents: Pathogenic model of hospital-acquired infectious diseases; Information on microorganisms and the drug resistance of pathogenic microorganisms in the hospital. Dosage of antibiotics is subject to the severity of disease, patient's immune status, susceptibility of pathogenic microorganisms and risk of infection with drug-resistant microorganisms, etc.
Additionally, antibiotics that need to be prioritized to be managed and used in hospitals are antibiotics chosen based on the following principles: antibiotics to treat infections caused by drug-resistant microorganisms, multidrug-resistant microorganisms or used in case of non-response or treatment failure with first-line antibiotics; Antibiotics with the high risk of resistance if being used widely, etc.
This Decision takes effect from the signing date.